<!DOCTYPE html>
<html>

  <head>
  <title>Venkat Krishnan | Small Molecule Based Therapies for NSCLC</title>
  <meta charset="utf-8">
  <meta http-equiv="content-type" content="text/html; charset=utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1">
  <meta name="description" content="This blog has some thoughts and projects that I've been working on recently. If you'd like to share some ideas on topics I've posted, email me at vkrishnan [at] ucsb.edu">
	<meta property="og:title" content="The Adventures of Venkat Krishnan"/>
    <meta property="og:url" content="https://vrobot.github.io"/>
    <meta property="og:site_name" content="The Adventures of Venkat Krishnan"/>
    <meta property="og:type" content="blog"/>
    <meta property="og:description" content="This blog has some thoughts and projects that I've been working on recently. If you'd like to share some ideas on topics I've posted, email me at vkrishnan [at] ucsb.edu">
    <meta property="og:image" content="https://vrobot.github.io/img/profile.jpg">  
 
  <link rel="canonical" href="https://vrobot.github.io/2016/11/26/small-molecule-therapies-nsclc">
  <link rel="shortcut icon" href="../../../../img/favicon.ico">
  <link rel="stylesheet" href="../../../../css/main.css">
  <link rel="stylesheet" href="../../../../css/syntax.css">
  <link href='http://fonts.googleapis.com/css?family=Source+Sans+Pro:200,300,400,600,700,900,200italic,300italic,400italic,600italic,700italic,900italic&subset=latin,latin-ext' rel='stylesheet' type='text/css'>
  <link href='http://fonts.googleapis.com/css?family=Source+Code+Pro:200,300,400,500,600,700,900&subset=latin,latin-ext' rel='stylesheet' type='text/css'>
  
  	<!-- The next section is for google authentication -->
	<meta name="google-site-verification" content="Kc8BTwj09E0jhjhIN29d7hZAkQPLDMQJyw5QFse_FQA" />
	
	<meta name="google-site-verification" content="2M8vRUQygiHkoVcm83x05Dsi2CFWe_VnF67gYtoJzCI" />
		
	<meta name="google-signin-client_id" content="523796096613-g7rilrn4nkiclnok6jrmo7bl9gevovlv.apps.googleusercontent.com">
	
	<script src="https://apis.google.com/js/platform.js" async defer></script>
	
	
	
	<!-- Google authentication code is in the above section -->
	
	<!-- Google Analytics -->
	
	<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-80729776-1', 'auto');
  ga('send', 'pageview');

</script>
	
	<!-- End of Google Analytics code -->
  
</head>


  <body>

    <div class="sidebar">
  <div class="container sidebar-sticky">
    <div class="sidebar-about">
<h1><a href="../../../../">Hi! I'm Venkat Krishnan.</a></h1>
	  <h1><a href="../../../../">I'm interested in Science and Technology and enjoy working on projects in these areas.</a></h1>
	<p class="tagline">&nbsp;</p>
    </div>

 <!--   <input type="checkbox" id="menu-icon"> -->
    <label class="menu-label" for="menu-icon"></label>
    <div class="trigger">
      <ul class="sidebar-nav">
        <li class="sidebar-nav-item active">
          <a href="../../../../">Home</a>
		  
		  
		  
		   <span> | </span>
		  
		  
		  
		  <a href="../../../../about/">About Me</a>
		  
        </li>

            
           
         

      </ul>
    </div>

    <p class="copyright">Â© 2018 Venkat Krishnan. All rights reserved.</p>
  </div>
</div>
</div>


    <div class="content container">
      <div class="posts">
  
 
	
 
  <div class="post">
   <div class="post">
    <h1 class="post-title">
      <a href="./">
        Selective Targeting of the L858R Mutation (EGFR) in Non-Small Cell Lung Cancer : A Mechanism for Advancing Targeted Chemotherapy and Minimizing Drug Resistance
      </a>
    </h1>

    <span class="post-date">26 November 2016</span>

	
<p>I've been working on a small molecule based targed cancer therapy project for the past few months. The abstract is below.</p>

<p>Lung cancer remains one of today's most deadly and intractable cancers. Non-
Small Cell Lung Cancer (NSCLC) accounts for roughly 85% of lung cancers, with
an extremely poor survival rate. Past Findings implicate the EGF/EGFR signaling
pathway in NSCLC, specifically L858R mutation occurrence in EGFR, suggesting
that a targeted therapy through L858R-mutated EGFR may provide a promising
approach to treatment. Therefore, this study attempts to identify a small
molecule that would bind to L858R-mutated EGFR to potentially carry cytotoxic
compounds into malignant cells. Using AutoDock Vina, 38000 small molecules
were screened for ability to bind to non-functional sites on L858R-mutated EGFR
(non-functional sites were used to reduce probability of acquired mutational
resistance) but not wildtype EGFR, and a top candidate (ZINC000004070447)
was identified. This candidate was then conjugated with Bovine Serum Albumin
to simulate the molecules linkage with chemotherapy drugs, and the complexs
efectiveness was tested through an ELISA. The results indicate that the identified
molecule does not interfere with EGF/EGFR interactions and efectively targets
only L858R-mutated EGFR. If proven to work in clinical trials, this research can
provide a breakthrough in targeted cancer therapy and prevent acquired resistance
to drugs</p>
    
	
<p>If you are intersted and would like to read more, the full research paper can be found <a href="https://vrobot.github.io/research/papers/nsclc/fonc-07-00104.pdf">here.</a> If you would like to learn more about the project, feel free to <a href="mailto:vkrishnan@ucsb.edu">email me!</a></p>
  </div>
  
  
  
</div>

<div class="pagination">


	<a class="pagination-item older" href="https://vrobot.github.io/2016/07/03/electric-cars/">&laquo; Older</a>
  
  
   <!-- <span class="pagination-item newer">Newer &raquo;</span> -->
  
   <!-- <span class="pagination-item older" href="" &laquo; Older</span>
  
  
    <span class="pagination-item newer" href="" Newer &raquo;</span> -->
	
	<a class="pagination-item newer" href="https://vrobot.github.io/2016/12/28/yahoo-finance-python-api/">Newer &raquo;</a>
  
</div>

    </div>

    <!-- MathJax -->
<script type="text/javascript"
  src="http://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML">
</script>

<div class="comments">
  <div id="disqus_thread"></div>
  <script type="text/javascript">
    var disqus_shortname = 'venkatkrishnan';
    (function() {
      var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true;
      dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js';
      (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq);
    })();
  </script>
  <noscript>Please enable JavaScript to view the <a href="http://disqus.com/?ref_noscript">comments powered by Disqus.</a></noscript>
</div>

    </div>


  </body>

  
  <!-- 
  
  Website content Copyright (c) 2016 Venkat Krishnan.

Page formatting credits are below :

Released under MIT License

Copyright (c) 2013 Mark Otto.

Permission is hereby granted, free of charge, to any person obtaining a copy of this software and associated documentation files (the "Software"), to deal in the Software without restriction, including without limitation the rights to use, copy, modify, merge, publish, distribute, sublicense, and/or sell copies of the Software, and to permit persons to whom the Software is furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM, OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE SOFTWARE.
  
  
  -->
  
  
</html>
